secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clearwater Analytics Holdings, Inc. (CWAN)
CIK:        0001866368
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001193125-25-004935
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clearwater Analytics to acquire Enfusion; $1.0B debt financing, $52.3M termination fee
--------------------------------------------------------------------------------

- Merger agreement signed Jan 10, 2025; Enfusion stockholders can elect mixed, stock, or cash consideration per share.
- Clearwater obtained $1.0B in new debt financing, plus cash on hand, to fund cash portion and fees; financing not a condition to closing.
- Enfusion must pay a $52,325,000 termination fee if it terminates for a superior proposal or board changes recommendation.
- Stockholders representing ~45% of Enfusion voting power signed support agreements to vote in favor and restrict share transfers.
- Conditions include Enfusion stockholder approval, HSR clearance, and effectiveness of Form S-4; deal must close by July 9, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1866368/000119312525004935/0001193125-25-004935-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1866368/000119312525004935/d921635d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-004935

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer